http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009132769-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2136ad3742072843758e5b86a1e01e9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
filingDate 2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57610e7c8ced343f7dea691ab2025996
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcba971278fa9ba61223482d5e5a6e80
publicationDate 2009-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009132769-A
titleOfInvention Lactide / ε-caprolactone copolymer for medical implants
abstract The present invention provides a flexible lactide / ε for medical implants that is extremely safe and does not contain higher alcohols, and is useful for producing medical implants that require flexibility such as artificial dura mater and artificial blood vessels. A caprolactone copolymer is provided. A copolymer of lactide and ε-caprolactone for use in a medical implant, wherein the molar ratio of lactide to ε-caprolactone (lactide / ε-caprolactone) is 40/60 to 60/40. The medical treatment has a weight average molecular weight of 100,000 to 500,000 or less, does not contain a higher alcohol component, and has a melting enthalpy of 10 J / g or less derived from crystals when heated and melted to form a molded product. Lactide / ε-caprolactone copolymer for medical use. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014167966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014167966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021205961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9527955-B2
priorityDate 2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001309969-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54605802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447936410

Total number of triples: 27.